The polydextrose market, valued at USD 245.37 million in 2025, is projected to reach USD 366.72 million by 2035, expanding at ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

The U.S. Health and Human Services Secretary made half-true or false statements about fluoride in public drinking water, ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared ...

Investing in our troops’ health is not a soft strategy, it’s a hard imperative. Just as we fund advanced weapons, we must fund precision nutrition. To feed the force is to fortify the nation.

The health of America’s children is in crisis. Nearly 75% of young adults in the United States do not meet the basic health ...

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...

Hers explores what food deserts are, how they get that way, and how you can take action—whether you live in one or not.

Over the past 30 years, cancer deaths have decreased by 34% in the United States. Although the United States accounts for 1 in 6 cancer cases worldwide, it makes up just 7% of global cancer deaths, ...